Navigation Links
Vitamin A signals offer clues to treating autoimmunity
Date:3/1/2009

Distributed around the body, dendritic cells act as the security alarms of the immune system. After sensing the presence of intruders, dendritic cells can transmit the alarm to white blood cells or tell them to relax, depending on the signals they send out.

Researchers at the Emory Vaccine Center and Yerkes National Primate Research Center have discovered that dendritic cells can respond to the same compound, through two different receptors, by sending out both stimulatory and calming messages at once.

The compound is zymosan, a component of yeast cell walls. However, the finding could guide scientists in designing vaccines against many infectious agents since the calming receptor is known to respond to bacteria and viruses as well as yeast. In addition, silencing the calming receptor's messages might boost the immune system's ability to fight a chronic infection.

The results are published in the March 2009 issue of Nature Medicine.

The calming receptor, known as TLR2 (Toll-like receptor 2), uses vitamin A to transmit its signals, which provides an explanation for the connection between vitamin A deficiency and autoimmune diseases. Vitamin A deficiency has been linked to diseases such as rheumatoid arthritis, lupus and type I diabetes.

This "two signals at once" feature of the immune system can be viewed as the result of an evolutionary tug of war, says senior author Bali Pulendran, PhD, professor of pathology and laboratory medicine at Emory University School of Medicine and Yerkes National Primate Research Center.

"The immune system has to provide a defense against infection, while avoiding the destruction of too much of the body along the way," he says. "At the same time, pathogens have evolved strategies to manipulate the immune system for their own purposes."

Working with Pulendran, postdoctoral fellow Santhakumar Manicassamy, PhD, examined which genes are turned on in dendritic cells by zymosan in cell culture. They were surprised to find that both zymosan and live Candida albicans, which causes yeast infections, turned on genes involved in converting vitamin A to its active form, retinoic acid.

"Others have seen that these genes are turned on constitutively in the gut, but seeing how they can be induced elsewhere is new," Pulendran says.

Manicassamy and colleagues found that dendritic cells use retinoic acid along with other chemical messengers to steer white blood cells into a regulatory mode, rather than an attack mode. For dendritic cells to do so, they need TLR2, since zymosan also activates another receptor called dectin-1, which sends out stimulatory signals.

The effects of zymosan and TLR2 can deter white blood cells from attacking nerve tissue in a mouse model of multiple sclerosis, the authors found.

In the model, mice are immunized against myelin, which forms a protective sheath around nerves. Injecting the mice with zymosan at the same time as immunization reduced the damage to their nerves.


'/>"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University
Source:Eurekalert

Related medicine news :

1. Iodine in Prenatal Vitamins Varies Widely
2. Too Little Vitamin D May Mean More Colds and Flu
3. B Vitamins Might Lower Stroke Risk
4. Vitamin supplements may protect against noise-induced hearing loss
5. Arab-American women need supplement to boost dangerously low vitamin D levels
6. Vitamins Do Older Women Little Good
7. Multivitamin use may offer no benefit in postmenopausal women
8. Vitamin D Deficit May Trigger MS Risk Gene
9. Vitamin Launches Online Face for Keep Em Cookin
10. UV Foundation Announces: February is Vitamin D Deficiency Month
11. APHA Lists Vitamin D Deficiency as Top Public Health Issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... The Cradle to ... Agency (EPA) in its new recommendations of standards and ecolabels for ... announced. , Cradle to Cradle Certified is recommended at the highest level across ...
(Date:1/24/2017)... ... January 24, 2017 , ... In comments submitted ... (PCORI) for developing a data access and sharing policy. The nation’s leading biomedical ... plan as part of award applications, and earmarking specified amounts of grant funding ...
(Date:1/24/2017)... ... January 24, 2017 , ... i2i Population Health, a national leader in population ... , “Cary’s broad financial background is an excellent fit for i2i,” says Justin ... financial operations skills we need to take the company to the next level of ...
(Date:1/24/2017)... ... 24, 2017 , ... Seceon , the only threat ... today announced a strategic partnership with Paramount , the Middle East’s regional ... their critical information assets and infrastructure, in a comprehensive and cost effective manner. ...
(Date:1/24/2017)... ... 2017 , ... Center for Hispanic Leadership (CHL) Academy , the talent ... Manager, Employee & Labor Relations at City of Hope , a world-renowned independent ... Month. City of Hope is committed to stay out in front of its communities’ ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... and PUNE, India , January ... published by Allied Market Research, titled, "Cold Chain Logistics ... Confectionary, Dairy & Frozen Dessert, Meat, Fish & Sea ... Analysis and Industry Forecasts, 2014-2022," projects that the global ... million by 2022, growing at a CAGR of 16% ...
(Date:1/24/2017)... , Jan. 24, 2017 Regeneron Pharmaceuticals, ... the Public today recognized 40 finalists in the Regeneron ... science and math competition for high school seniors. Finalists ... potential of their research projects. The finalists ... from March 9-15 to undergo a rigorous judging ...
(Date:1/24/2017)... -- Research and Markets has announced the addition of ... Material - Forecast to 2025" report to their offering. ... The Global Implantable ... around 5.4% over the next decade to reach approximately $54.28 billion ... market is witnessing include 3D medical printing is expected to develop ...
Breaking Medicine Technology: